Evidence map›Paper›PMID 38594717›Full record

ArticleTranslational neurodegeneration2024

Pathophysiological subtypes of mild cognitive impairment due to Alzheimer's disease identified by CSF proteomics.

Daniela Moutinho, Vera M Mendes, Alessandro Caula, Sara C Madeira, Inês Baldeiras, Manuela Guerreiro, Sandra Cardoso, Johan Gobom, Henrik Zetterberg, Isabel Santana and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational neurodegeneration, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daniela Moutinho *Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Vera M Mendes *CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.
Alessandro CaulaLASIGE, Faculty of Sciences, University of Lisbon, 1649-028, Lisbon, Portugal.
Sara C MadeiraLASIGE, Faculty of Sciences, University of Lisbon, 1649-028, Lisbon, Portugal.
Inês BaldeirasCNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.
Manuela GuerreiroFaculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Sandra CardosoFaculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Johan GobomDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, S-431 80, Mölndal, Sweden.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, S-431 80, Mölndal, Sweden.
Isabel SantanaCNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.
Alexandre De MendonçaFaculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Helena AidosLASIGE, Faculty of Sciences, University of Lisbon, 1649-028, Lisbon, Portugal.
Bruno ManadasCNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal. bmanadas@cnc.uc.pt.ORCID 0000-0002-2087-4042

Funding

Fundação para a Ciência e a Tecnologia PTDC/MED-NEU/27946/2017
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseaseCognitive DysfunctionHumansProteomicstau Proteinstau Proteins

Identifiers

PMID38594717
PMCPMC11003166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.